Biomendex

For freedom to operate, join the story.

General Information
Company Name
Biomendex
Founded Year
2018
Location (Offices)
Finland +1
Founders / Decision Makers
Number of Employees
15
Industries
Biotechnology, Health Care, Manufacturing
Funding Stage
Grant
Social Media

Biomendex - Company Profile

Biomendex is a Finnish biotechnology startup founded in 2018, specializing in the development and manufacturing of adaptable synthetic bone substitute materials for bone regeneration. Their innovative product, Adaptos®, represents the first bioactive bone graft substitute that surgeons can customize to fit the patient's needs, mimicking bone by being resilient and bioactive. The company's mission is to revolutionize the treatment of bone voids by delivering versatile and improved medical devices to operating theaters, ultimately enhancing surgical outcomes and minimizing operational risks in bone regeneration. With a focus on Biotechnology, Health Care, and Manufacturing, Biomendex aims to provide the freedom to operate by leveraging cutting-edge technology in the field of bone regeneration. Currently, no specific information is available regarding the company's last investment and the parties involved.

Funding Rounds & Investors of Biomendex (0)

View All

There is no investment information

Latest News of Biomendex

View All

No recent news or press coverage available for Biomendex.

Similar Companies to Biomendex

View All
NovaBone - Similar company to Biomendex
NovaBone Advancing Regenerative Medicine Through Bioactive Bone Graft Technology
Isto Biologics - Similar company to Biomendex
Isto Biologics Dedicated to providing advanced solutions for spine, orthopedics, and sports medicine. #helpingpatientshealfaster
Synergy Biomedical - Similar company to Biomendex
Synergy Biomedical Next Generation Bioactive Glass Solutions